Posted in | News | Events

Founding Director of HORIBA Jobin Yvon IBH Awarded For Pioneering the UK Fluorescence Lifetime Industry

HORIBA Scientific, a global leader in measurement and analysis solutions for research and industry, and world leader in fluorescence solutions is proud to announce that David Birch, PhD., was awarded the 2020 Dennis Gabor Award by the Institute of Physics (IOP).  

Dr. Birch is an Emeritus Professor of Photophysics at the University of Strathclyde and a founding Director of HORIBA Jobin Yvon IBH Ltd., one of the earliest corporate spin-offs in Scotland. His contributions in the fluorescence sector included research on techniques, multi-disciplinary applications, and developing instrumentation for measuring fluorescence lifetimes, including the TCSPC (time-correlated Single-Photon Counting) technique.

The Dennis Gabor Medal, named for the inventor of holography and 1971 Nobel Prize winner, is awarded for distinguished contributions to the app
lication of physics in industry.

As Chairman at IBH, Dr. Birch pioneered TCSPC fluorescence lifetime spectroscopy and his recent research has focused on the application of fluorescence to molecular grand challenges at the biomedical interface. He championed the merger of IBH and HORIBA, solidifying HORIBA’s leading fluorescence market share.

Dr. Birch has published over 250 peer-reviewed journal articles, and his contributions to research and new products have been recognized through Fellowships of the IOP, the Royal Society of Edinburgh, the Royal Society of Chemistry and Visiting Chairs at Texas Christian University, Kyoto Institute of Technology, the Czech Technical University and the University of Madras. Presently he is co-founding Editor-in-Chief of IOP’s Methods and Applications in Fluorescence.

I am very honored to receive the award. It provides further evidence of HORIBA’s leadership in fluorescence and represents not only my success over many years but also that of many wonderful colleagues in HORIBA, IBH, and the University of Strathclyde.

Dr. Birch, Chairman, IBH

We are extremely proud of David’s accomplishments and recognition in the fluorescence community. His work over many decades brought the techniques of fluorescence lifetime measurement and its applications to fundamental biophysical research to laboratories all over the world.  Similar to the comparison of X-Ray to MRI, the fluorescence lifetime technique allows researchers to observe molecular properties and interactions on ultrafast timescales, critical to the understanding of protein/drug interactions, biophysics, materials science, and photophysics.  As HORIBA, we are very honored to work with David and the entire IBH team. Congratulations, David, on this prestigious Award!

Dr. Sal Atzeni, Executive Vice President, HORIBA Scientific

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    HORIBA. (2020, December 09). Founding Director of HORIBA Jobin Yvon IBH Awarded For Pioneering the UK Fluorescence Lifetime Industry. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=55144.

  • MLA

    HORIBA. "Founding Director of HORIBA Jobin Yvon IBH Awarded For Pioneering the UK Fluorescence Lifetime Industry". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=55144>.

  • Chicago

    HORIBA. "Founding Director of HORIBA Jobin Yvon IBH Awarded For Pioneering the UK Fluorescence Lifetime Industry". AZoM. https://www.azom.com/news.aspx?newsID=55144. (accessed November 23, 2024).

  • Harvard

    HORIBA. 2020. Founding Director of HORIBA Jobin Yvon IBH Awarded For Pioneering the UK Fluorescence Lifetime Industry. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=55144.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.